Articles

Results 6 to 10 of 65
Most popular |Most recent


At a glance: pharmaceutical merger review in Canada

Canada - June 30 2020 This article looks at some of the key legal and practical issues surrounding the competition authorities' review of mergers in the pharmaceutical sector in Canada, including review triggers and thresholds.

Erin Brown, John Greiss, Stephen Nattrass.

Snapshot: anticompetitive unilateral conduct in the pharmaceutical sector in Canada

Canada - June 30 2020 A look at key practical considerations surrounding abuse of dominance and other anticompetitive unilateral conduct in the pharmaceutical sector in Canada, including IP rights abuse and pricing conduct.

Erin Brown, John Greiss, Stephen Nattrass.

Anticompetitive unilateral conduct in the pharmaceutical sector in Canada

Canada - September 6 2019 An overview of practical considerations surrounding abuse of dominance and other anticompetitive unilateral conduct in the pharmaceutical sector in Canada, including IP rights abuse and pricing conduct.

Bradley Schneider, Erin Brown, Ian Trimble, Stephen Nattrass.

Anticompetitive agreements in the pharmaceutical sector in Canada

Canada - September 6 2019 An overview of essential considerations surrounding anticompetitive agreements in the pharmaceutical sector in Canada, including the assessment framework and special issues with vertical agreements.

Bradley Schneider, Erin Brown, Ian Trimble, Stephen Nattrass.

Pharmaceutical antitrust law in Canada

Canada - September 6 2019 A structured guide to antitrust law in the pharmaceutical sector in Canada, including the legislative and regulatory framework, merger review, anticompetitive agreements and abuse of dominance.

Bradley Schneider, Erin Brown, Ian Trimble, Stephen Nattrass.